Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Sarpogrelate That Prevent Contrast-induced Nephropathy

NCT01165567 is registered in ClinicalTrials.gov with Seoul National University Boramae Hospital as lead sponsor.

NCT NCT01165567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01165567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Sarpogrelate That Prevent Contrast-induced Nephropathy
Lead sponsor
Seoul National University Boramae Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2009
Completion date
December 31, 2010
Enrollment
212 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease